- Debiglip 50 M SR Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation helps improve insulin sensitivity and secretion.
- Debiglip 50 M SR Tablet reduces the risk of diabetes-related complications.
- It is beneficial for patients who struggle with weight gain associated with other diabetes medications.
- Debiglip 50 M SR Tablet can help maintain stable blood glucose levels throughout the day.
- This medication is suitable for use alongside a healthy diet and regular exercise.
- Debiglip 50 M SR Tablet minimizes the chances of hypoglycemia compared to other antidiabetic therapies.
- It supports overall metabolic health by addressing insulin resistance.
- Debiglip 50 M SR Tablet is often prescribed when monotherapy with Metformin is insufficient.
- This combination therapy enhances glycemic control more effectively than Metformin alone.
- Debiglip 50 M SR Tablet is indicated for adults with Type 2 diabetes who require additional treatment options.
- The sustained-release formulation allows for once-daily dosing, improving patient compliance.
- Debiglip 50 M SR Tablet can be used in conjunction with other antidiabetic medications as directed by a healthcare provider.
- This therapy aids in achieving target HbA1c levels in diabetic patients.
- Debiglip 50 M SR Tablet is designed to be taken with food to reduce gastrointestinal side effects.
Debiglip 50 M SR Tablet - Strip of 15
Compositions : Vildagliptin 50mg + Metformin 500mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Leeford Healthcare Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Debiglip 50 M SR Tablet is a specialized pharmaceutical formulation designed for the management of Type 2 diabetes mellitus. This medication combines two potent active ingredients: Metformin and Vildagliptin, which work synergistically to control blood sugar levels effectively. The key composition of Debiglip 50 M SR Tablet includes 500 mg of Metformin and 50 mg of Vildagliptin, making it a powerful option for patients struggling with diabetes. As a sustained-release tablet, Debiglip 50 M SR Tablet ensures a gradual release of its active components, providing prolonged therapeutic effects throughout the day. The primary purpose of Debiglip 50 M SR Tablet is to improve glycemic control in adults with Type 2 diabetes, particularly when diet and exercise alone do not suffice. By utilizing this combination therapy, patients can achieve better blood glucose management, reducing the risk of complications associated with uncontrolled diabetes. Debiglip 50 M SR Tablet falls under the therapeutic category of antidiabetic medications, specifically designed to enhance insulin sensitivity and secretion while decreasing hepatic glucose production. This dual action makes Debiglip 50 M SR Tablet an essential part of diabetes management for many individuals. The formulation is particularly beneficial for those who may experience weight gain or hypoglycemia with other diabetes medications, as it offers a more balanced approach to blood sugar control. In summary, Debiglip 50 M SR Tablet is a comprehensive solution for managing Type 2 diabetes, combining the strengths of Metformin and Vildagliptin to provide effective and sustained glycemic control.
Product Details
Debiglip 50 M SR Tablet works through a dual mechanism involving its active ingredients, Metformin and Vildagliptin. These components work together to regulate blood sugar levels effectively.
- Metformin: Reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues.
- Vildagliptin: Increases insulin secretion from pancreatic beta cells in response to elevated blood glucose levels.
- This combination helps lower fasting and postprandial blood glucose levels.
- Debiglip 50 M SR Tablet also decreases the absorption of glucose from the intestines.
- The sustained-release formulation ensures a gradual release of active ingredients, providing prolonged glycemic control.
- By improving insulin action and secretion, Debiglip 50 M SR Tablet helps maintain stable blood sugar levels throughout the day.
- This dual action reduces the risk of hypoglycemia compared to other diabetes medications.
- Debiglip 50 M SR Tablet should be taken orally as directed by your healthcare provider.
- The recommended dosage is typically one tablet daily, preferably taken with food to minimize gastrointestinal discomfort.
- It is important to take Debiglip 50 M SR Tablet at the same time each day for optimal results.
- The duration of treatment with Debiglip 50 M SR Tablet will be determined by your doctor based on your individual needs and response to therapy.
- Do not crush or chew the tablet; swallow it whole with a glass of water.
- If you miss a dose of Debiglip 50 M SR Tablet, take it as soon as you remember unless it is almost time for your next dose.
- Avoid taking two doses at once to compensate for a missed dose.
- Your doctor may adjust your dosage based on your blood sugar levels and overall health status.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Debiglip 50 M SR Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication in controlling blood sugar levels.
- Avoid excessive consumption of sugary foods and beverages that can spike blood glucose levels.
- Stay hydrated by drinking plenty of water throughout the day while on Debiglip 50 M SR Tablet.
- Monitor blood sugar levels regularly to track the effectiveness of Debiglip 50 M SR Tablet and adjust lifestyle accordingly.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while using this medication.
Safety Advice
Side Effects
- Common side effects of Debiglip 50 M SR Tablet include nausea and dizziness.
- Some patients may experience headaches or tremors while using this medication.
- Weight gain can occur but is generally less than with other diabetes medications.
- Hypoglycemia (low blood sugar) may happen, especially if combined with other antidiabetic drugs.
- Serious side effects include lactic acidosis, which requires immediate medical attention if symptoms like rapid breathing or persistent nausea occur.
- Consult your doctor if you experience abdominal pain, fatigue, or jaundice while taking Debiglip 50 M SR Tablet.
Precautions and Warnings
- Debiglip 50 M SR Tablet should not be used in patients with severe kidney impairment or liver disease.
- Inform your doctor about any existing medical conditions before starting treatment with Debiglip 50 M SR Tablet.
- Avoid alcohol consumption while taking this medication due to the increased risk of lactic acidosis.
- Pregnant or breastfeeding women should consult their healthcare provider before using Debiglip 50 M SR Tablet.
- This medication may affect your ability to drive or operate machinery; use caution if you experience dizziness or low blood sugar symptoms.
- Regular monitoring of kidney function is recommended during treatment with Debiglip 50 M SR Tablet.
- If you are scheduled for surgery, inform your doctor about your diabetes treatment plan, including Debiglip 50 M SR Tablet usage.
FAQs
Debiglip 50 M SR Tablet is primarily used for managing Type 2 diabetes mellitus by controlling blood sugar levels.
2. How should I take Debiglip 50 M SR Tablet?
Debiglip 50 M SR Tablet should be taken orally with food, typically once daily as prescribed by your healthcare provider.
3. What are the common side effects of Debiglip 50 M SR Tablet?
Common side effects include nausea, dizziness, headaches, and potential weight gain.
4. Can I drink alcohol while taking Debiglip 50 M SR Tablet?
It is advisable to avoid alcohol while taking Debiglip 50 M SR Tablet due to the risk of lactic acidosis.
5. Is Debiglip 50 M SR Tablet safe during pregnancy?
Pregnant women should consult their healthcare provider before using Debiglip 50 M SR Tablet.
6. What should I do if I miss a dose of Debiglip 50 M SR Tablet?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose.
7. Are there any drug interactions with Debiglip 50 M SR Tablet?
Always inform your doctor about all medications you are taking to avoid potential interactions with Debiglip 50 M SR Tablet.
Instructions
Storage and Disposal
More Information
| SKU | 100990 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Leeford Healthcare Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Debiglip 50 M SR Tablet is a specialized pharmaceutical formulation designed for the management of Type 2 diabetes mellitus. This medication combines two potent active ingredients: Metformin and Vildagliptin, which work synergistically to control blood sugar levels effectively. The key composition of Debiglip 50 M SR Tablet includes 500 mg of Metformin and 50 mg of Vildagliptin, making it a powerful option for patients struggling with diabetes. As a sustained-release tablet, Debiglip 50 M SR Tablet ensures a gradual release of its active components, providing prolonged therapeutic effects throughout the day. The primary purpose of Debiglip 50 M SR Tablet is to improve glycemic control in adults with Type 2 diabetes, particularly when diet and exercise alone do not suffice. By utilizing this combination therapy, patients can achieve better blood glucose management, reducing the risk of complications associated with uncontrolled diabetes. Debiglip 50 M SR Tablet falls under the therapeutic category of antidiabetic medications, specifically designed to enhance insulin sensitivity and secretion while decreasing hepatic glucose production. This dual action makes Debiglip 50 M SR Tablet an essential part of diabetes management for many individuals. The formulation is particularly beneficial for those who may experience weight gain or hypoglycemia with other diabetes medications, as it offers a more balanced approach to blood sugar control. In summary, Debiglip 50 M SR Tablet is a comprehensive solution for managing Type 2 diabetes, combining the strengths of Metformin and Vildagliptin to provide effective and sustained glycemic control.
- Debiglip 50 M SR Tablet effectively lowers blood sugar levels in patients with Type 2 diabetes.
- This formulation helps improve insulin sensitivity and secretion.
- Debiglip 50 M SR Tablet reduces the risk of diabetes-related complications.
- It is beneficial for patients who struggle with weight gain associated with other diabetes medications.
- Debiglip 50 M SR Tablet can help maintain stable blood glucose levels throughout the day.
- This medication is suitable for use alongside a healthy diet and regular exercise.
- Debiglip 50 M SR Tablet minimizes the chances of hypoglycemia compared to other antidiabetic therapies.
- It supports overall metabolic health by addressing insulin resistance.
- Debiglip 50 M SR Tablet is often prescribed when monotherapy with Metformin is insufficient.
- This combination therapy enhances glycemic control more effectively than Metformin alone.
- Debiglip 50 M SR Tablet is indicated for adults with Type 2 diabetes who require additional treatment options.
- The sustained-release formulation allows for once-daily dosing, improving patient compliance.
- Debiglip 50 M SR Tablet can be used in conjunction with other antidiabetic medications as directed by a healthcare provider.
- This therapy aids in achieving target HbA1c levels in diabetic patients.
- Debiglip 50 M SR Tablet is designed to be taken with food to reduce gastrointestinal side effects.
Debiglip 50 M SR Tablet works through a dual mechanism involving its active ingredients, Metformin and Vildagliptin. These components work together to regulate blood sugar levels effectively.
- Metformin: Reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues.
- Vildagliptin: Increases insulin secretion from pancreatic beta cells in response to elevated blood glucose levels.
- This combination helps lower fasting and postprandial blood glucose levels.
- Debiglip 50 M SR Tablet also decreases the absorption of glucose from the intestines.
- The sustained-release formulation ensures a gradual release of active ingredients, providing prolonged glycemic control.
- By improving insulin action and secretion, Debiglip 50 M SR Tablet helps maintain stable blood sugar levels throughout the day.
- This dual action reduces the risk of hypoglycemia compared to other diabetes medications.
- Debiglip 50 M SR Tablet should be taken orally as directed by your healthcare provider.
- The recommended dosage is typically one tablet daily, preferably taken with food to minimize gastrointestinal discomfort.
- It is important to take Debiglip 50 M SR Tablet at the same time each day for optimal results.
- The duration of treatment with Debiglip 50 M SR Tablet will be determined by your doctor based on your individual needs and response to therapy.
- Do not crush or chew the tablet; swallow it whole with a glass of water.
- If you miss a dose of Debiglip 50 M SR Tablet, take it as soon as you remember unless it is almost time for your next dose.
- Avoid taking two doses at once to compensate for a missed dose.
- Your doctor may adjust your dosage based on your blood sugar levels and overall health status.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Debiglip 50 M SR Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication in controlling blood sugar levels.
- Avoid excessive consumption of sugary foods and beverages that can spike blood glucose levels.
- Stay hydrated by drinking plenty of water throughout the day while on Debiglip 50 M SR Tablet.
- Monitor blood sugar levels regularly to track the effectiveness of Debiglip 50 M SR Tablet and adjust lifestyle accordingly.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while using this medication.
Side Effects
- Common side effects of Debiglip 50 M SR Tablet include nausea and dizziness.
- Some patients may experience headaches or tremors while using this medication.
- Weight gain can occur but is generally less than with other diabetes medications.
- Hypoglycemia (low blood sugar) may happen, especially if combined with other antidiabetic drugs.
- Serious side effects include lactic acidosis, which requires immediate medical attention if symptoms like rapid breathing or persistent nausea occur.
- Consult your doctor if you experience abdominal pain, fatigue, or jaundice while taking Debiglip 50 M SR Tablet.
Precautions and Warnings
- Debiglip 50 M SR Tablet should not be used in patients with severe kidney impairment or liver disease.
- Inform your doctor about any existing medical conditions before starting treatment with Debiglip 50 M SR Tablet.
- Avoid alcohol consumption while taking this medication due to the increased risk of lactic acidosis.
- Pregnant or breastfeeding women should consult their healthcare provider before using Debiglip 50 M SR Tablet.
- This medication may affect your ability to drive or operate machinery; use caution if you experience dizziness or low blood sugar symptoms.
- Regular monitoring of kidney function is recommended during treatment with Debiglip 50 M SR Tablet.
- If you are scheduled for surgery, inform your doctor about your diabetes treatment plan, including Debiglip 50 M SR Tablet usage.
Debiglip 50 M SR Tablet is primarily used for managing Type 2 diabetes mellitus by controlling blood sugar levels.
2. How should I take Debiglip 50 M SR Tablet?
Debiglip 50 M SR Tablet should be taken orally with food, typically once daily as prescribed by your healthcare provider.
3. What are the common side effects of Debiglip 50 M SR Tablet?
Common side effects include nausea, dizziness, headaches, and potential weight gain.
4. Can I drink alcohol while taking Debiglip 50 M SR Tablet?
It is advisable to avoid alcohol while taking Debiglip 50 M SR Tablet due to the risk of lactic acidosis.
5. Is Debiglip 50 M SR Tablet safe during pregnancy?
Pregnant women should consult their healthcare provider before using Debiglip 50 M SR Tablet.
6. What should I do if I miss a dose of Debiglip 50 M SR Tablet?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose.
7. Are there any drug interactions with Debiglip 50 M SR Tablet?
Always inform your doctor about all medications you are taking to avoid potential interactions with Debiglip 50 M SR Tablet.
Storage and Disposal
| SKU | 100990 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Leeford Healthcare Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account